At a glance
- Originator Bristol-Myers Squibb
- Class Antiplatelets
- Mechanism of Action Phosphoric diester hydrolase inhibitors; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis; Unstable angina pectoris
Most Recent Events
- 04 Nov 1997 No-Development-Reported for Thrombosis in USA (Unknown route)
- 04 Nov 1997 No-Development-Reported for Unstable angina pectoris in USA (Unknown route)
- 12 Jun 1995 New profile